4DMedical Limited
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more
4DMedical Limited (FDMDF) - Total Assets
Latest total assets as of June 2025: $94.81 Million USD
Based on the latest financial reports, 4DMedical Limited (FDMDF) holds total assets worth $94.81 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
4DMedical Limited - Total Assets Trend (2015–2025)
This chart illustrates how 4DMedical Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
4DMedical Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
4DMedical Limited's total assets of $94.81 Million consist of 18.0% current assets and 82.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.3% |
| Accounts Receivable | $1.29 Million | 1.4% |
| Inventory | $919.63K | 1.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $23.86 Million | 25.2% |
| Goodwill | $42.71 Million | 45.1% |
Asset Composition Trend (2015–2025)
This chart illustrates how 4DMedical Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: 4DMedical Limited's current assets represent 18.0% of total assets in 2025, a decrease from 39.8% in 2015.
- Cash Position: Cash and equivalents constituted 7.3% of total assets in 2025, down from 24.4% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 70.0% of total assets, an increase from 10.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 45.1% of total assets.
4DMedical Limited Competitors by Total Assets
Key competitors of 4DMedical Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
4DMedical Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - 4DMedical Limited generates 0.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - 4DMedical Limited is currently not profitable relative to its asset base.
4DMedical Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.89 | 1.78 | 0.38 |
| Quick Ratio | 0.84 | 1.74 | 0.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.19 Million | $ 17.16 Million | $ -16.66 Million |
4DMedical Limited - Advanced Valuation Insights
This section examines the relationship between 4DMedical Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 27.27 |
| Latest Market Cap to Assets Ratio | 1.45 |
| Asset Growth Rate (YoY) | -21.0% |
| Total Assets | $94.81 Million |
| Market Capitalization | $137.91 Million USD |
Valuation Analysis
Above Book Valuation: The market values 4DMedical Limited's assets above their book value (1.45 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: 4DMedical Limited's assets decreased by 21.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for 4DMedical Limited (2015–2025)
The table below shows the annual total assets of 4DMedical Limited from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $94.81 Million | -21.00% |
| 2024-06-30 | $120.02 Million | +29.16% |
| 2023-06-30 | $92.92 Million | +25.04% |
| 2022-06-30 | $74.31 Million | -19.78% |
| 2021-06-30 | $92.64 Million | +485.40% |
| 2020-06-30 | $15.82 Million | +75.36% |
| 2019-06-30 | $9.02 Million | +65.51% |
| 2018-06-30 | $5.45 Million | +10.24% |
| 2017-06-30 | $4.95 Million | +352.80% |
| 2016-06-30 | $1.09 Million | +61.67% |
| 2015-06-30 | $675.64K | -- |